The stock is trading above its 5-day, 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day simple moving averages ...

This summary covers various health news briefs including AstraZeneca's breast cancer drug trial results, a bird flu case in ...

Researchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib to standard tyrosine kinase inhibitor ...

The Oliver Patch Project was born. Three years after launching, the charity has provided more than 1,600 children from ...

Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the ...

Nearly 200 chemicals connected to breast cancer are used in the making of food packaging and plastic tableware, and dozens of ...

The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss ...

There hasn’t been a new class of drugs approved to help smokers quit since Pfizer's Chantix reached the market nearly two ...

Experts have developed a breakthrough small-molecule drug, a 'protein degrader'. This molecule, called ACBI3, could potentially lead to new therapies independent of KRAS mutation type, improving ...

Experts from the University of of Dundee's Centre for Targeted Protein Degradation (CeTPD), working with Boehringer Ingelheim scientists, have developed a breakthrough small-molecule drug, a "protein ...

The Fresh Toast - New data bout cancer and cannabis give physicians and researchers information about how to talk with ...

AstraZeneca said on Monday its experimental precision drug developed with Japan's Daiichi Sankyo did not significantly ...